Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Meningeal inflammation in multiple sclerosis: The key to the origin of cortical lesions?
[Molecular targeted therapy for neuroimmunological diseases].
Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica.
Noise robust spatially regularized myelin water fraction mapping with the intrinsic B1 -error correction based on the linearized version of the extended phase graph model.
Panic disorder as presenting symptoms of multiple sclerosis.
Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis.
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.
17β-estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis).
Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
Getting Beyond the Ganglion Cell: Morphometric Adjustments for Retinal Optical Coherence Tomography in Multiple Sclerosis.
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study.
Modeling the course and outcomes of multiple sclerosis is statistical twaddle-Yes.
Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting.
An initial top-down proteomic analysis of the standard cuprizone mouse model of multiple sclerosis.
Childhood body mass index and multiple sclerosis risk: a long-term cohort study.
Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis.
A methylenetetrahydrofolate reductase gene polymorphism in multiple sclerosis.
Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.
[Illness, health and sunlight].

Pages